Evaluating Progression Free Survival Among Veteran Population With Stage IV Non-Small Cell Immunotherapy vs Chemo- ImmunotherapySeptember 2, 2022Lung CancerOncology
MYO1E DNA Methylation in U.S. Military Veterans With Adenocarcinoma of the Lung Is Associated With Increased Mortality RiskAugust 30, 2022Lung CancerOncology
Molecular Profiling of Lung Malignancies in Veterans: What We Have Learned About the Impact of Agent Orange ExposureAugust 30, 2022Lung CancerOncology
Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non–Small Cell Lung Cancer: A Meta-analysisAugust 15, 2022Lung CancerOncology
One in four NSCLC patients respond poorly to COVID-19 vaccineAugust 3, 2022Lung CancerOncologyCancerCOVID-19 Updates
Quality of life benefit exaggerated in some cancer studiesJuly 7, 2022OncologyBreast CancerGenitourinary CancerLung CancerMelanomaMixed TopicsRare Diseases
